Deciphering GABBR1-centered drug targets to fight viral infection with preexisting diabetes

Asymptomatic Transmissibility Calls for Implementing a Zero-COVID Strategy to End the Current Global Crisis

(2022) Chaobao Zhang et al.   Frontiers in Cellular and Infection Microbiology

The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity

(2021) Marcin F Osuchowski et al.   Lancet Respiratory Medicine

Existing bitter medicines for fighting 2019‐nCoV‐associated infectious diseases

(2020) Xiangqi Li et al.   FASEB JOURNAL

Characteristics of Hospitalized Adults With COVID-19 in an Integrated Health Care System in California

(2020) Laura C. Myers et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis

(2020) Yifan Meng et al.   Journal of Hematology & Oncology

COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives

(2020) Masataka Nishiga et al.   Nature Reviews Cardiology

Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study

(2020) Andrew Clark et al.   Lancet Global Health

Rediscovery of Caffeine: An Excellent Drug for Improving Patient Outcomes while Fighting WARS

(2020) Lianyong Liu et al.   CURRENT MEDICINAL CHEMISTRY

BitterDB: taste ligands and receptors database in 2019

(2018) Ayana Dagan-Wiener et al.   NUCLEIC ACIDS RESEARCH